Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
3.
Cutis ; 109(1): 49-53, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35180057

RESUMEN

Individuals with chronic illnesses turn to online communities to engage in asynchronous peer-to-peer exchanges to better understand and manage their disease. Messages and advice exchanged by online users with vitiligo are not well characterized. We conducted a qualitative study to explore the content exchanged by individuals with vitiligo in online forums. An interpretive research paradigm was utilized to assess public online forum content. A systematic search using the phrases online forum vitiligo support, vitiligo online message board, and vitiligo forums identified 39 relevant forums; 9 of them met inclusion criteria, with 382 total anonymous users. Major themes and subthemes included vitiligo disease management, homeopathy/home remedies, psychosocial impact, public perceptions, and camouflage/concealment.


Asunto(s)
Hipopigmentación , Vitíligo , Enfermedad Crónica , Humanos , Internet , Investigación Cualitativa , Vitíligo/terapia
4.
J Dermatolog Treat ; 33(3): 1208-1212, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-32772743

RESUMEN

BACKGROUND: The novel coronavirus (COVID-19) has an affinity for almost every organ system, including the skin. This review article will compile and compare dermatology guidelines related to the dermatologic care of patients during the COVID-19 pandemic. OBJECTIVE: To review and compare the available guidelines and recommendations on use of biologics and other systemic therapies in dermatology patients. METHODS: We conducted a search for guidelines and recommendations for dermatology providers, with specific attention to the management of biologics and non-biologic systemic agents during COVID-19. International and United States-based guidelines specific to the field of dermatology and guidance for healthcare providers were used as inclusion criteria. Available registries were included as well. CONCLUSION: The guidelines stress a shared decision-making approach with risk-benefit analysis and treatment strategy modifications tailored to each unique patient case. The guidelines were all concordant with one another in highlighting the importance that patients should not discontinue their medications without first speaking with their providers.


Asunto(s)
Productos Biológicos , COVID-19 , Dermatología , Productos Biológicos/uso terapéutico , Humanos , Pandemias , Sistema de Registros , Estados Unidos
5.
Dermatol Online J ; 27(1)2021 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-33560793

RESUMEN

Pyoderma gangrenosum (PG) is an inflammatory, ulcerative condition that is characterized by painful ulcers that commonly present on the lower extremities. Up to half of PG cases are associated with underlying systemic disease, including inflammatory bowel disease, various autoimmune conditions, and malignancy. Another well-known association is the manifestation of PG with recreational cocaine use, especially cocaine contaminated with the adulterant agent levamisole. Once utilized for its immunomodulatory capabilities, levamisole was withdrawn from the market in 2002. It has since been repurposed to potentiate the amphetamine-like effects and duration of cocaine and has reduced preparation cost. We present a 52-year-old woman with chronic maxillary sinusitis and cocaine use disorder presenting with a two-week history of painful ulcers on bilateral lower extremities, each with a purulent base and undermined, violaceous borders. Urine toxicology was positive for cocaine and serologic studies were positive for cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) and lupus anticoagulant. Underlying conditions, especially that of granulomatosis with polyangiitis, were considered and ultimately ruled out. The patient's lesions exhibited a marked response with a short course of oral corticosteroids, typical of PG associated with levamisole. This case highlights the crucial role that drug abstinence plays in the prevention of recurrence.


Asunto(s)
Anticuerpos Anticitoplasma de Neutrófilos/sangre , Trastornos Relacionados con Cocaína/complicaciones , Contaminación de Medicamentos , Levamisol/efectos adversos , Piodermia Gangrenosa/inducido químicamente , Piodermia Gangrenosa/inmunología , Corticoesteroides/uso terapéutico , Betametasona/análogos & derivados , Betametasona/uso terapéutico , Enfermedad Crónica , Diagnóstico Diferencial , Femenino , Humanos , Sinusitis Maxilar/complicaciones , Persona de Mediana Edad , Prednisona/uso terapéutico , Piodermia Gangrenosa/tratamiento farmacológico , Piodermia Gangrenosa/patología
8.
Int Breastfeed J ; 14: 11, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30815026

RESUMEN

Background: Since 2010, the World Health Organization recommends lifelong antiretroviral treatment for all women living with HIV, and exclusive breastfeeding for six-months followed by breastfeeding until 24-months for all HIV positive mothers. Nevertheless, many mothers living with HIV do not initiate breastfeeding or stop prematurely, and many countries are still in the process of updating their national infant feeding guidelines to align with World Health Organization recommendations. We sought to understand uptake of breastfeeding and factors that influence decision-making regarding infant feeding in women living with and without HIV who receive ante- and postnatal care at a primary healthcare setting. Methods: Programmatic data on infant feeding intentions and practices among women attending an ante-and postnatal clinic service at a primary care clinic in Johannesburg, South Africa were summarized using descriptive statistics. Qualitative interviews were conducted with 12 healthcare providers, 12 women living with HIV who were breastfeeding and 10 who were formula feeding. Interviews were analyzed using a content analysis approach. Results: Pregnant women living with HIV were less likely to express an intent to breastfeed (71% vs 99%). During the first 6 months postpartum, mothers living with HIV were also less likely to exclusively breastfeed compared to HIV-negative mothers. Mixed messages during infant feeding counselling, social and economic factors, and fear of HIV transmission influenced women's choices to initiate and continue breastfeeding. Conclusions: As infant feeding guidelines for women living with HIV have evolved rapidly in the past 10 years, uniform messages on the low risk of mother-to-child transmission of HIV associated with breastfeeding while on ART and on introduction of complementary foods after 6 months of age are needed.


Asunto(s)
Lactancia Materna/psicología , Infecciones por VIH/fisiopatología , Adulto , Lactancia Materna/estadística & datos numéricos , Conducta de Elección , Consejo , Estudios de Evaluación como Asunto , Miedo , Femenino , Infecciones por VIH/psicología , Infecciones por VIH/transmisión , Personal de Salud/educación , Personal de Salud/psicología , Humanos , Transmisión Vertical de Enfermedad Infecciosa , Madres , Embarazo , Sudáfrica , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...